Viral Fusion Inhibitors

A(H1N1) is still out there and could still strike at any time. What’s worst, new variations and strains could appear that would be more lethal than the current pandemic. The effects could be devastating.

But we’re prepared, right? We all got our Tamiflu… we all got our vaccines.

If you’ve led to believe that… then Big Pharma scored another win.

The bigwigs from Big Pharma wants people to believe that Tamiflu and other vaccines could prevent any complications of A(H1N1), or for any other deadly viruses for that matter. However, these same bigwigs has always been on the attack (ooops…. protecting the public… that’s what they say) againts natural flu treatments… calling them witch’s brew, snake oil or any other moniker they could think of.

But reports have been coming out that they’re actually pointing fingers in the wrong direction.

Governments around the world has been stockpiling Tamiflu, A(H1N1) vaccines and other similar medications in fear of viral rebounds. However, the harmful side effects of these drugs far outweigh the benefits that could be derived as reported time and again by several health sectors, communities and independent research companies.

One such study came out from the British Medical Journal, wherein researchers compiled and analyzed 20 studies that delved into the benefits and potential adverse effects of Tamiflu.

A new review has come out in the British Medical Journal– and the results aren’t good for the makers of Tamiflu. Researchers tried to compile and analyze 20 studies on the benefits and adverse effects of Tamiflu. What’s alarming was that these researchers could not get relevant information from the authors of these studies and from the makers of Tamiflu themselves.

Are they hiding something from the public?

What these researchers reported was a lack or “no confidence in claims that Tamiflu reduces the risk of complications of influenza in otherwise healthy adults.” Previous evidence could be unreliable and are urging governments to closely study and monitor continued use of Tamiflu and these vaccines.

Funny thing though… the World Health Organization have no plans of changing their guidelines about the use of Tamiflu and other vaccines, and continue administration despite the negative reports that indicate that they should do so.

==============

February 22, 2010 — The rapid influenza diagnostic test (RIDT) for swine-origin 2009 A (H1N1) influenza virus (S-OIV) in children may be most useful in young children who present early after symptom onset, according to the results of a large pediatric cohort study reported online February 15 in Pediatrics.

“Data on the test performance of the RIDT for S-OIV have been limited,” write Michael Hawkes, MD, from the University of Toronto in Ontario, Canada, and colleagues. “The few available reports in mixed adult-pediatric populations have shown variable sensitivity between 11% and 69%…. The rapidly evolving pandemic of novel 2009 [S-OIV] demands that accurate and practical diagnostics be urgently evaluated for their potential clinical utility.”

The goal of this study was to assess the diagnostic accuracy of RIDT and direct fluorescent antibody (DFA) assay for S-OIV, using reverse-transcription polymerase chain reaction (RT-PCR) as the reference standard. Between May 22 and July 25, 2009, the investigators prospectively recruited 820 children from birth to age 17 years who were evaluated for influenza-like illness in the emergency department of a pediatric referral hospital (n = 651) and a community pediatric clinic (n = 169).

To examine the sensitivity and specificity for S-OIV of RIDT (performed on-site) and of DFA, these tests were compared with the sensitivity and specificity of RT-PCR. In addition, the sensitivity of RIDT for S-OIV was compared with sensitivity for seasonal influenza during 2 preceding seasons.

For RIDT, sensitivity for S-OIV was 62% (95% confidence interval [CI], 52% – 70%), and specificity was 99% (95% CI, 92% – 100%). Sensitivity of DFA was 83% (95% CI, 75% – 89%), which was significantly higher than that of RIDT (P < .001). When using DFA supplemented with culture as the reference standard, RIDT sensitivity for S-OIV was similar to that for seasonal influenza. Sensitivity of RIDT for influenza viruses was significantly higher in children not older than 5 years of age (P =.003) and in those evaluated not longer than 2 days after onset of symptoms (P < .001).

“The sensitivity of RIDT for detection of S-OIV is higher than recently reported in mixed adult-pediatric populations but remains suboptimal,” the study authors write. “Nonetheless, RIDTs may have a role in clinical practice for diagnosis of S-OIV in young children who present early after symptom onset, for whom the test sensitivity is superior.”

Limitations of this study include lack of generalizability to children with preexisting medical comorbidities and possible variation in test collection methods.

“Our findings support a recent Centers for Disease Control and Prevention interim guidance statement that, when influenza viruses are circulating in a community, a positive RIDT result indicates that influenza infection is likely present; however, a negative test result does not rule out infection,” the study authors conclude. “In the face of a negative test result, a diagnosis of influenza should still be considered, empiric therapy and appropriate infection-control measures should be instituted if indicated, and confirmatory testing should be sought if necessary. Future studies are warranted to examine the clinical utility and cost-effectiveness of RIDTs in the context of the current S-OIV pandemic.”

The Canadian Institutes of Health Research/SickKids Foundation, the Canadian Institutes of Health Research, and the University of Toronto supported this study. The study authors have disclosed no relevant financial relationships.

Pediatrics. Published online February 15, 2010.

Clinical Context

Obesity or simply the state of exceeding the ideal body weight by 100 lbs. for males, or 80 lbs. for females, is associated with a higher risk of disease, which leads to early death. Apparently, with the numbers rising to approximately 350 million obese people around the world, wherein about 500, 000 of them are Filipinos; it is alarming to note that some of these patients are very young and need surgical intervention.

Interestingly, while many of us are trying to take pleasure in an unhealthy diet and in a lifestyle with less or no exercise, these patients are beginning to feel the pains and emotional regrets of being obese. Largely affected are women who suffer ridicule and discrimination that significantly affect their self-confidence and integrity. Studies have shown that obese people also experience complications like diabetes, heart problems, osteoarthritis, stroke, cancers, weak stamina, and chronic depression, among others.

It is well-known that increased food intake and decreased physical activity eventually result in obesity. In the recent years, however, scientific research discovered another possible reason; they identified an epidemic known as the Human Adenovirus 36 (Ad-36) or the Obesity Virus, which can be caught as easily as a common cold from other people’s coughs, sneezes and dirty hands.

Dr. Nikhil Dhurandhar, an associate professor at the Pennington Biomedical Research Center, in Lousiana, said the parasitic virus, causes sniffles and sore throats as it infects the lungs then whisks around the body forcing fat cells to become fatter and multiply at a tremendous rate. In their experiments, Ad-36 has been shown to cause obesity in chicken, mice and monkey. In one test, Ad-36 infected 30% of obese humans but only 11% of thinner humans and these subjects are heavier compared with their Ad36-negative counterparts.

Ad-36 was first described in 1980, when it was originally isolated from a German girl with diabetes. Afterwards, prevalence of obesity increased by 30% between 1980 and 1990, and by 61% between 1990 and 2000; with no indication that this numbers are lessening.

Understanding the alarming growth of the obese population worldwide, health advocate Mr. Hans Palacios and Civic Leader for Public Awareness and Education Mr. Jake Ortiz indulge in efforts to spread a public awareness campaign about obesity and the Ad-36 virus, at DWIZ every Sunday at 10-11:00 AM, in partnership with www.thebignm.com - the only network management website for Filipinos.

Obesity virus attacks the body’s immune system, and interferes with its normal functions. This in turn makes the body more vulnerable to other deadly viruses like influenza, typhoid, dengue, hepatitis, hanta virus, chicken pox, herpes, gastroenteritis, swine flu (A H1N1), and HIV/AIDS. Researchers reported some 50 adenovirus strains that cause respiratory and eye infections, and various vaccines for these are not yet developed.

Backed by 15 years of study and clinical tests, Alfa HFI is a breakthrough discovery and was created by scientists as the nature’s most powerful broad spectrum antiviral solution to address this concern. It is an all-natural, pure and safe dietary supplement. It is refined and formulated from the powerful plant and animal bio-molecules found in ancient deposits of decomposed organic matter, which are humus layers of the earth’s soil that play an important role in the transfer of minerals within the living organism.

Alfa HFI works by penetrating the invading ultramicroscopic viruses and preventing their attachment into healthy cells through agents called Viral Fusion Inhibitors, which block and wrap the viruses in a coating substance. If the virus cannot attach to the cell’s DNA, it cannot survive and reproduce. Alfa HFi also has the amazing Alert Mode Ability that signals the immune system to flush the viruses out.

Alfa HFi also works both as preventive and immune system supportive and will be a valuable support for people seeking relief from nutritional imbalances, immune system disorders and viral diseases. It has anti-inflammatory, antibacterial, antibiotic, anti-allergic, anti-arthritic, anti-ulcerogenic, immuno-modulatory and other health benefis.

As a potent chelator and detoxifier, it attracts and attaches itself to toxic heavy metals and other toxins and removes them from the body as waste. It contains trace amounts of 70 mineral phyto-nutrients that give more energy. It increases polysaccharide sugars and combats the spread of free radicals in the body. It improves stress resistance, appetite, and the ability to focus during strenuous activities.

Consumption of Alfa HFI immediately restores and supercharges the body’s resistance to disease and infection by helping the body in manufacturing necessary glycoproteins within. It also perks up the gastrointestinal tract as pro-biotic, strengthens the joints and bones, provides amino acids and electrolytes, and boosts oxygen for the red blood cells.

Enzacta prides itself on having Alfa HFI Humic/Fuvic Acid Supplement as a product of their state-of-the-art technology and special proprietary process called BioReady Nutrients© (BRNs).  BRNs are nutritional complexes extracted, concentrated and naturally-enhanced for better bio-availability.

For more information, visit www.enzacta.com or call Enzacta at 706-5876 and look for Ms. Arra Inayon, company nurse and corporate researcher.